InvestSMART

Mach7 Technologies Limited (ASX:M7T)

ALERT: Price-sensitive ASX Announcement for M7T
Current share price for M7T : $0.310 0.025 (8.77%)+
Announcement
Release
24 Apr 2026 8:34AM
Price at Release
$0.285
Full Release
download
Summary
Mach7 Technologies Limited's Q3 FY26 results presentation highlights a solid financial positioning with A$19.2 million in closing cash and no debt. The company achieved a Contracted Annual Recurring Revenue (CARR) of A$25.8 million and an Annual Recurring Revenue (ARR) run rate of A$22.8 million, reflecting positive commercial transformations and operational efficiencies. As part of its strategic progress, Mach7 has improved product delivery aligned with customer needs and is advancing towards enterprise imaging architecture and intelligent cloud orchestration. The company is seeing early traction in digital pathology and is enhancing its commercial execution through improved CRM, pricing strategies, and a strengthened sales capacity to support future growth. Furthermore, a scalable and diversified partner ecosystem is being developed to drive revenue and geographic expansion.
Key Points
  • Closing cash of A$19.2 million with no debt.
  • CARR of A$25.8 million and ARR run rate of A$22.8 million.
  • Improved product delivery and strategic roadmap progress.
  • Early traction in digital pathology.
  • Enhanced commercial execution and CRM strategies.
  • Scalable, diversified partner ecosystem for growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.